ORIG3N
ORIG3N is a biotechnology company developing breakthrough treatments for rare genetically inherited diseases with targets in heart, liver, and neurodegenerative indications. It was founded in 2014 and is based in Boston, Massachusetts.
ORIG3N
Industry:
Biotechnology Health Care Medical Personal Health
Founded:
2014-04-10
Address:
Boston, Massachusetts, United States
Country:
United States
Website Url:
http://www.orig3n.com
Total Employee:
11+
Status:
Active
Total Funding:
76.17 M USD
Technology used in webpage:
SPF LetsEncrypt Nginx Amazon IPv6 JsDelivr GoDaddy DNS BootstrapCDN Ubuntu Ruby On Rails Token
Similar Organizations
AZTherapies
AZTherapies is a clinical stage biotech company developing breakthrough treatments for neuroinflammation-related diseases.
DermBiont
DermBiont is a biotech company that develops skin microbiome therapeutics to treat and prevent skin diseases.
Gelesis
Gelesis is a biotechnology company developing first-in-class therapeutics to safely treat obese, overweight, and diabetic patients.
Meryx
Meryx is a biotechnology company that develops orally bio-available cancer drugs targeting receptor tyrosine kinases.
Orchid
Orchid is a reproductive technology startup that is capable of detecting rare genetic disorders.
Vascugen
Vascugen is a biotechnology company developing regenerative medicine for treatment of intractable vascular diseases.
Watchmaker Genomics
Watchmaker Genomics is a biotechnology company that focuses on breakthrough applications for reading, writing, and editing DNA.
ZO Skin Health
ZO Skin Health, Inc. develops and delivers innovative skincare solutions that optimize skin health around the globe.
Current Employees Featured
Robin Smith Founder & CEO @ ORIG3N
Founder & CEO
2014-04-01
Kate Blanchard Chief Operating Officer / Founder @ ORIG3N
Chief Operating Officer / Founder
2014-04-01
Founder
Acquisitions List
| Date | Company | Article | Price |
|---|---|---|---|
| 2017-11-22 | Interleukin Genetics | Interleukin Genetics acquired by ORIG3N | N/A |
Investors List
Haitong International Securities Group
Haitong International Securities Group investment in Series B - ORIG3N
180 Degree Capital
180 Degree Capital investment in Series B - ORIG3N
DEFTA Partners
DEFTA Partners investment in Series B - ORIG3N
KTB Ventures
KTB Ventures investment in Series B - ORIG3N
Spectrum Health Ventures
Spectrum Health Ventures investment in Series B - ORIG3N
Alexandria Venture Investments
Alexandria Venture Investments investment in Series B - ORIG3N
Vectr
Vectr investment in Series B - ORIG3N
Hatteras Venture Partners
Hatteras Venture Partners investment in Series B - ORIG3N
MMIC Investment Holdings
MMIC Investment Holdings investment in Series B - ORIG3N
Mountain Group Capital
Mountain Group Capital investment in Series B - ORIG3N
Newest Events participated
Participated in SXSW 2017
on 2017-03-10 as exhibitor
Official Site Inspections
http://www.orig3n.com Semrush global rank: 3.72 M Semrush visits lastest month: 3.67 K
- Host name: a2aa9ff50de748dbe.awsglobalaccelerator.com
- IP address: 3.33.130.190
- Location: Seattle United States
- Latitude: 47.6348
- Longitude: -122.3451
- Metro Code: 819
- Timezone: America/Los_Angeles
- Postal: 98109
More informations about "ORIG3N"
ORIG3N - Crunchbase Company Profile & Funding
Organization. ORIG3N . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. ... ORIG3N is a biotechnology company developing …See details»
Orig3n - Overview, News & Similar companies | ZoomInfo.com
Orig3n Receives FDA Emergency Use Authorization (EUA) For Coronavirus 2019 Test Orig3n, Inc., a Boston-based company pioneering the future of wellness and health through genetics …See details»
Orig3n Company Profile | Management and Employees List
Orig3n also invests in breakthrough cell therapy programs by utilizing cutting-edge cellular science to develop personalized therapies for repairing tissue damage and treating disease. …See details»
ORIG3N - Funding, Financials, Valuation & Investors - Crunchbase
Nov 22, 2017 ORIG3N is funded by 15 investors. Sekhmet Ventures and Haitong International Securities Group are the most recent investors. ORIG3N has a post-money valuation in the …See details»
Seaport Diagnostics - Craft
Apr 13, 2020 Seaport Diagnostics (formerly known as Orig3n) is a biotechnology research company. It helps people understand the links between their genes and how their minds and …See details»
ORIG3N - VentureRadar
Founded in 2014, ORIG3N exists at the intersection of biological science and emerging technology. Through our DNA tests and community events, we help people understand the …See details»
Orig3n, Inc. Company Profile | Boston, MA - Dun & Bradstreet
Find company research, competitor information, contact details & financial data for Orig3n, Inc. of Boston, MA. Get the latest business insights from Dun & Bradstreet.See details»
ORIG3N - Updates, News, Events, Signals & Triggers - Crunchbase
Organization. ORIG3N . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. Research and Development Insight Details. Powered by …See details»
Orig3n Company Information - Funding, Investors, and More
Get information on funding, investors, industries, and more for Orig3n. See Orig3n company profile and funding data.See details»
ORIG3N - Products, Competitors, Financials, Employees, …
ORIG3N is a biotechnology company that operates at the intersection of biological science and emerging technology. The company offers DNA tests that provide genetic information and …See details»
Orig3n Revenue, Growth & Competitor Profile - IncFact.com
Feb 17, 2025 Orig3n's Annual Report & Profile shows critical firmographic facts: What is the company's size? (Annual sales and employees) Orig3n's annual revenues are $10 - $100 …See details»
Orig3n - campfire.wiki
ORIG3N is a biotechnology company, collects DNA samples and researches and develops treatments for genetically inherited diseases. Orig3n helps people understand the links …See details»
Orig3n - Company info. interviews, news - biopharmatrend.com
Orig3n . Founded 2014. Patents 23. Publications 4. Technologies Stem Cells Startups. ORIG3N is a biotechnology company developing breakthrough treatments for rare genetically inherited …See details»
ORIG3N - Crunchbase
Organization. ORIG3N . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. Similar Companies. Edit Similar Companies Section. …See details»
The Democratization Of Medical Research: Why This Biotech
Nov 20, 2015 Orig3n is focusing on creating neurons, heart cells and liver cells to study rare, genetically-inherited diseases. When serial entrepreneur Robin Smith founded Orig3n in 2014, …See details»
ORIG3N, Producing Patient-Specific iPS Cells – Interview with …
Nov 12, 2020 ORIG3N, a biotechnology start-up headquartered in Boston, is attracting global attention for several reasons.First, it has created the world’s largest blood cell repository. …See details»
Orig3n Is Trying to Build the World's Largest Stem Cell Bank
Dec 16, 2015 Orig3n plans to use the completed biobank to create neurons, heart cells, and liver cells, and to study diseases like Parkinson’s and ALS. It hopes the repository will grow large …See details»
ORIG3N, World’s Largest Blood Cell Repository for iPS
Dec 12, 2017 ORIG3N has a simple-yet-elegant website that was designed by a team member who previously worked at Apple. This team member was attracted to ORIG3N’s fast-moving …See details»
ORIG3N - Contacts, Employees, Board Members, Advisors
ORIG3N is a biotechnology company developing breakthrough treatments for rare genetically inherited diseases. New. ... Experience the new Crunchbase, powered by AI . Organization. …See details»
DNA Company Tampered With Results, Former Employees Say
Sep 11, 2019 Seventeen people employed by Orig3n as managers, lab technicians, software engineers, marketers, and salespeople from summer 2015 to fall 2018 say the company …See details»